The program, called THRIVE, will back seven different teams pursuing various groups of conditions affecting different organ ...

Metformin, a drug prescribed to tens of millions of people with type 2 diabetes, is producing measurable shifts in molecular ...

A study tracking more than 10,000 patients with early-stage, obesity-related cancers found that those taking GLP-1 receptor ...

Irritable bowel syndrome (IBS) is a common condition that affects more than 10% of the general population, causing recurrent abdominal pain, bloating, constipation and diarrhea.

Atsena Therapeutics, a clinical-stage gene therapy company focused on reversing and preventing blindness from inherited retinal diseases, today announced the selection of a lead clinical candidate for ...

Opus Genetics, Inc. (Nasdaq: IRD) (the “Company”, “Opus Genetics” or “Opus”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients ...

The AI conversation is still too narrowly framed. Most debates assume intelligence is fundamentally computational, that ...

Few areas of the body face more daily stress and potential damage than the stomach, which must manage everything we swallow.

Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these ...

Researchers at the Icahn School of Medicine at Mount Sinai and the Lieber Institute for Brain Development have identified ...

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...